Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Royal DSM N.V.
  6. News
  7. Summary
    DSM   NL0000009827

ROYAL DSM N.V.

(DSM)
  Report
Real-time Euronext Amsterdam  -  11:35 2022-11-30 am EST
122.30 EUR   +1.96%
07:37aDSM Begins Construction of New Manufacturing Facility in Scotland to Boost Bovaer Production
MT
11/22Transcript : Koninklijke DSM N.V., Firmenich International SA - M&A Call
CI
11/17Dutch Nutrition Group DSM Secures SBTi Validation for Climate Targets
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Days
:
Hours
:
Minutes
:
Seconds

Transcript : Firmenich International SA, Koninklijke DSM N.V. - M&A Call

05/31/2022 | 09:00am EST
[Audio Gap] Ourselves on our capacity to work in partnerships with customers and other parties to create new products and solutions as well as entirely new product categories and science-based...


ę S&P Capital IQ 2022
All news about ROYAL DSM N.V.
07:37aDSM Begins Construction of New Manufacturing Facility in Scotland to Boost Bovaer Produ..
MT
11/22Transcript : Koninklijke DSM N.V., Firmenich International SA - M&A Call
CI
11/17Dutch Nutrition Group DSM Secures SBTi Validation for Climate Targets
MT
11/01Global markets live: Sony, Toyota, Pfizer, Apple, Wells Fargo...
MS
11/01Transcript : Koninklijke DSM N.V., Q3 2022 Sales/ Trading Statement Call, Nov..
CI
11/01European shares kick off November on bright note
RE
11/01Dutch Nutrition Giant DSM Trims 2022 Profit Outlook Amid Higher Energy, Input Costs
MT
11/01Dutch chemicals group DSM cuts full-year profit outlook
RE
11/01Dutch Nutrition Group DSM's Q3 Sales Climb 20% Amid Resilient Market Demand
MT
10/05Biotechnology Group Bachem To Buy New Site In Switzerland
MT
More news
Analyst Recommendations on ROYAL DSM N.V.
More recommendations
Financials
Sales 2022 8 473 M 8 738 M 8 738 M
Net income 2022 665 M 685 M 685 M
Net Debt 2022 238 M 245 M 245 M
P/E ratio 2022 29,3x
Yield 2022 2,13%
Capitalization 21 153 M 21 814 M 21 814 M
EV / Sales 2022 2,52x
EV / Sales 2023 2,08x
Nbr of Employees 21 760
Free-Float 98,7%
Chart ROYAL DSM N.V.
Duration : Period :
Royal DSM N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROYAL DSM N.V.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Last Close Price 122,30 €
Average target price 159,16 €
Spread / Average Target 30,1%
EPS Revisions
Managers and Directors
Dimitri de Vreeze Member-Management Board
GÚraldine Matchett Member-Management Board
Thomas Leysen Chairman-Supervisory Board
Eileen A. Kennedy Member-Supervisory Board
Pradeep Pant Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
ROYAL DSM N.V.-38.23%21 452
NESTLÉ S.A.-12.70%322 526
MONDELEZ INTERNATIONAL, INC.1.96%90 199
ARCHER-DANIELS-MIDLAND COMPANY44.25%52 983
GENERAL MILLS, INC.22.94%49 168
KRAFT HEINZ9.61%47 821